New drugs.
Hussar
D A
DA
D020909:Acarbose; D000925:Anticoagulants / Q000627:therapeutic use*; D017985:Dalteparin / Q000627:therapeutic use*; D017277:Drug Approval; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007546:Isoquinolines / Q000627:therapeutic use*; D009732:Nursing Care; D011804:Quinolines / Q000627:therapeutic use*; D019258:Saquinavir; D014312:Trisaccharides / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000925:Anticoagulants; D017320:HIV Protease Inhibitors; D007004:Hypoglycemic Agents; D007546:Isoquinolines; D011804:Quinolines; D014312:Trisaccharides; D019258:Saquinavir; D017985:Dalteparin; D020909:Acarbose